CAS 1686149-74-5

BMS-589154

CAS: 1686149-74-5

Formel: C₂₆H₂₇N₅O₄

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 473.5237

Ref: IN-DA00ASL3

Apixaban Impurity 4 (BMS-728626-01)

CAS: 1686149-74-5

Formel: C₂₆H₂₇N₅O₄

Farbe und Form: White To Off-White Solid

Molekulargewicht: 473.53

Ref: 4Z-A-10205

5''''-Methyl-apixaban

Kontrolliertes Produkt

CAS: 1686149-74-5

Impurity Apixaban
Applications Analytical standard impurity of drug.

Formel: C₂₆H₂₇N₅O₄

Farbe und Form: Neat

Molekulargewicht: 473.524

Ref: TR-M331278

1-(4-Methoxyphenyl)-6-(4-(5-methyl-2-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide

CAS: 1686149-74-5

Reinheit: 98%

Molekulargewicht: 473.5329895019531

Ref: 10-F789888

Apixaban Impurity 4

CAS: 1686149-74-5

Formel: C₂₆H₂₇N₅O₄

Molekulargewicht: 473.53

Ref: ST-EA-CP-A3060

5''''-Methyl-apixaban

CAS: 1686149-74-5

5''''-Methyl-apixaban is a drug product that is synthesized in the laboratory. It has been shown to be metabolized by cytochrome P450 enzymes, which are found in the liver, and eliminated by glucuronidation. This compound has been shown to have antiplatelet activity and is used for the prevention of stroke in patients with atrial fibrillation who cannot tolerate warfarin or those who need a higher dose of warfarin than can be achieved with standard doses. 5''''-Methyl-apixaban also inhibits platelet aggregation, leading to decreased blood clot formation. 5''''-Methyl-apixaban has been shown to have a number of metabolites including apixaban, which is formed through oxidation; apixanone, which is formed through hydrolysis; and apixanol, which is formed through conjugation with glucuronic acid. Apixanone has been shown to have more potent antiplatelet activity

Formel: C₂₆H₂₇N₅O₄

Reinheit: Min. 95%

Molekulargewicht: 473.5 g/mol

Ref: 3D-LSC14974